The purpose of this study is to assess the safety and efficacy of hypofractionated stereotactic LINAC radiotherapy with 10 fractions at 6 Gy per fraction at the 80% isodose for the planning target volume (PTV) in patients with uveal melanoma. Patients will be followed-up for 10 years after radiotherapy regarding local tumor control, visual acuity, secondary complications and survival.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
155
10 fractions of stereotactic linear accelerator radiotherapy with 6 Gy per fraction at the 80% isodose for the planning target volume.
Department of Ophthalmology and the Department of Radiotherapy and Radiobiology, Medical University of Vienna
Vienna, State of Vienna, Austria
RECRUITINGlocal tumor control (tumor dimensions; secondary complications; visual acuity; survival
histological assessment of the fraction of living cells in eyes requiring secondary enucleation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.